167 related articles for article (PubMed ID: 14504342)
1. Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide.
Van Camp G; Flamez A; Cosyns B; Goldstein J; Perdaens C; Schoors D
Neurology; 2003 Sep; 61(6):859-61. PubMed ID: 14504342
[TBL] [Abstract][Full Text] [Related]
2. Pergolide use in Parkinson disease is associated with cardiac valve regurgitation.
Baseman DG; O'Suilleabhain PE; Reimold SC; Laskar SR; Baseman JG; Dewey RB
Neurology; 2004 Jul; 63(2):301-4. PubMed ID: 15277624
[TBL] [Abstract][Full Text] [Related]
3. Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.
Corvol JC; Anzouan-Kacou JB; Fauveau E; Bonnet AM; Lebrun-Vignes B; Girault C; Agid Y; Lechat P; Isnard R; Lacomblez L
Arch Neurol; 2007 Dec; 64(12):1721-6. PubMed ID: 18071034
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease.
Van Camp G; Flamez A; Cosyns B; Weytjens C; Muyldermans L; Van Zandijcke M; De Sutter J; Santens P; Decoodt P; Moerman C; Schoors D
Lancet; 2004 Apr; 363(9416):1179-83. PubMed ID: 15081648
[TBL] [Abstract][Full Text] [Related]
5. [Severe insuffiency of the aortic and tricuspidal valves associated with pergolide use].
van Strater AC; Bax JJ; van Hilten JJ; Jukema JW
Ned Tijdschr Geneeskd; 2005 Apr; 149(16):891-4. PubMed ID: 15868996
[TBL] [Abstract][Full Text] [Related]
6. Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline.
Kenangil G; Ozekmekçi S; Koldas L; Sahin T; Erginöz E
Clin Neurol Neurosurg; 2007 May; 109(4):350-3. PubMed ID: 17307289
[TBL] [Abstract][Full Text] [Related]
7. Valvular heart disease in pergolide-treated Parkinson's disease.
Scozzafava J; Takahashi J; Johnston W; Puttagunta L; Martin WR
Can J Neurol Sci; 2006 Feb; 33(1):111-3. PubMed ID: 16583734
[TBL] [Abstract][Full Text] [Related]
8. Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
Bares M; Rektorová I; Krajcovicová L; Rektor I
J Neurol; 2008 Oct; 255(10):1596; author reply 1597. PubMed ID: 18758889
[No Abstract] [Full Text] [Related]
9. [Effects of low-dose pergolide therapy on cardiac valves in patients with Parkinson's disease].
Muraki M; Mikami T; Kitaguchi M; Sugawara T; Isonishi K; Kaneko S; Kashiwaba T; Moriwaka F; Yamada S; Onozuka H; Tsutsui H
J Cardiol; 2005 Dec; 46(6):221-7. PubMed ID: 16389741
[TBL] [Abstract][Full Text] [Related]
10. Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide.
Chung EJ; Yoon WT; Kim JY; Lee WY
Mov Disord; 2006 Apr; 21(4):586-7. PubMed ID: 16482572
[No Abstract] [Full Text] [Related]
11. Pergolide in Parkinson's disease: time for a change?
Grosset KA; Grosset DG
Lancet; 2004 Jun; 363(9424):1907-8. PubMed ID: 15183636
[No Abstract] [Full Text] [Related]
12. Valvular heart disease in patients taking pergolide.
Pritchett AM; Morrison JF; Edwards WD; Schaff HV; Connolly HM; Espinosa RE
Mayo Clin Proc; 2002 Dec; 77(12):1280-6. PubMed ID: 12479512
[TBL] [Abstract][Full Text] [Related]
13. Valvular heart disease and the use of dopamine agonists for Parkinson's disease.
Zanettini R; Antonini A; Gatto G; Gentile R; Tesei S; Pezzoli G
N Engl J Med; 2007 Jan; 356(1):39-46. PubMed ID: 17202454
[TBL] [Abstract][Full Text] [Related]
14. The older Parkinson's disease drugs pergolide and cabergoline have been linked to heart problems. Are there any new Parkinson's drugs which are safer for patients with heart risks?
Heart Advis; 2009 Aug; 12(8):8. PubMed ID: 21188763
[No Abstract] [Full Text] [Related]
15. Valvular heart disease associated with taking low-dose pergolide for restless legs syndrome.
Worthington A; Thomas L
Eur J Echocardiogr; 2008 Nov; 9(6):828-30. PubMed ID: 18579494
[TBL] [Abstract][Full Text] [Related]
16. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
Kim JY; Chung EJ; Park SW; Lee WY
Mov Disord; 2006 Aug; 21(8):1261-4. PubMed ID: 16685692
[TBL] [Abstract][Full Text] [Related]
17. Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.
Dewey RB; Reimold SC; O'Suilleabhain PE
Arch Neurol; 2007 Mar; 64(3):377-80. PubMed ID: 17353380
[TBL] [Abstract][Full Text] [Related]
18. Valvular heart disease in patients with Parkinson's disease treated with pergolide. Course following treatment modifications.
Dupuy D; Lesbre JP; Gérard P; Andrejak M; Godefroy O
J Neurol; 2008 Jul; 255(7):1045-8. PubMed ID: 18560792
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine use and the risk of valvular heart disease.
Tan LC; Ng KK; Au WL; Lee RK; Chan YH; Tan NC
Mov Disord; 2009 Feb; 24(3):344-9. PubMed ID: 18989898
[TBL] [Abstract][Full Text] [Related]
20. Valvular heart disease in patients taking pergolide.
Waller EA; Kaplan J; Heckman MG
Mayo Clin Proc; 2005 Aug; 80(8):1016-20. PubMed ID: 16092580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
